Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Vivani Medical, Inc.
Insider Aaron Mendelsohn of Vivani Medical, Inc. reported a change in beneficial ownership of securities as of October 15, 2026. This filing provides details regarding the insider's equity position change via Form 4.…more
Vivani Medical, Inc.
Vivani Medical is registering the resale of up to 3,947,368 shares of common stock issuable upon the exercise of outstanding warrants issued under a March 1, 2024, securities purchase agreement. This prospectus supplement facilitates the potential resale of these shares by warrant holders and does not involve the company selling any new securities.…more
Vivani Medical, Inc.
Vivani Medical announced that its subsidiary, Cortigent, is proceeding with a merger with ClearOne, with pricing and closing of the transaction expected in October 2026. Upon completion, Cortigent will become a wholly owned subsidiary of ClearOne.…more
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Vivani Medical Announces Participation in Upcoming Investor Conferences…more
Vivani Medical will participate in two upcoming investor conferences in New York to hold meetings with investors and partners. The company's management team will present updates, though no specific material business milestones were announced.…more
●●●●●●●● ●●●●● ●●●●●●
Vivani Medical announced its participation in two upcoming investor conferences scheduled for September. These events are standard investor relations activities and do not provide immediate material impact on the stock price.…more
●●●●●●●● ●●●●● ●●●●●●
비바니 메디컬이 세마글루타이드 기반 비만 치료제 임플란트 'NPM-139'의 임상 1상 투약을 성공적으로 마쳤습니다. 올해 11월 임상 결과 발표를 앞두고 있으며, 향후 임상 2상 진입을 위한 기반을 마련했습니다.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.